Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2005-02-15
2005-02-15
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C558S194000, C558S210000, C558S211000
Reexamination Certificate
active
06855702
ABSTRACT:
Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
REFERENCES:
patent: 4659701 (1987-04-01), Wuest et al.
patent: 5231112 (1993-07-01), Janoff et al.
patent: 5561122 (1996-10-01), Pettit
patent: 5674906 (1997-10-01), Hatanaka et al.
patent: 6025507 (2000-02-01), Klar et al.
patent: 6670344 (2003-12-01), Venit et al.
patent: WO 0048590 (2000-08-01), None
patent: WO 0048591 (2000-08-01), None
patent: WO 0214329 (2002-02-01), None
Dahlheim Charles E.
Dali Mandar V.
Dali Manisha M.
Huang Yande
Tejwani Ravindra W.
Biswas, Esq. Naomi S.
Bristol--Myers Squibb Company
Desai Rita
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
LandOfFree
Combretastatin A-4 phosphate prodrug mono-and di-organic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combretastatin A-4 phosphate prodrug mono-and di-organic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combretastatin A-4 phosphate prodrug mono-and di-organic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3490946